Resident characteristics | All | Influenza A(H3N2) | hMPV and hCoV | Negatif |
---|---|---|---|---|
N = 22 (%) | N = 11 (%) | N = 2 (%) | N = 9 (%) | |
Age (min–max) | 86.4 (72–96) | 87.4 (72–96) | 88.5 (83–94) | 84.8 (76–93) |
Gender, Female | 18 (81.8 %) | 10 (91 %) | 1 (50 %) | 7 (77.7 %) |
Symptoms | ||||
Fever >38 °C | 18 (81.8 %) | 10 (91 %) | 2 (100 %) | 6 (66.6 %) |
Cough | 22 (100 %) | 11 (100 %) | 2 (100 %) | 9 (100 %) |
Headache | 3 (13.6 %) | 1 (9.1 %) | 0 | 2 (22.2 %) |
Dyspnoea | 2 (9.1 %) | 1 (9.1 %) | 0 | 1 (11.1 %) |
Rhinitis | 12 (54.5 %) | 8 (72.7 %) | 1 (50 %) | 3 (33.3 %) |
Asthenia | 11 (50 %) | 7 (63.6 %) | 0 | 4 (44.4 %) |
Conjunctival hyperemia | 2 (9.1 %) | 2 (18.2 %) | 0 | 0 |
Other | 6 (27.3 %) | 4 (36.4 %) | 0 | 2 (22.2 %) |
Seasonal influenza vaccination 2014–2015 | 21 (95.5 %) | 10 (91.0 %) | 2 (100 %) | 9 (100 %) |
Chronic disease | 17 (77.2 %) | 8 (72.7 %) | 2 (100 %) | 7 (77.7 %) |
Oseltamivir treatement | 0 | 0 | 0 | 0 |
Antibiotic treatement | 8 (36.4 %) | 4 (36.4 %) | 2 (100 %) | 2 (22.2 %) |
Influenza-related hospitalization | 1 (4.5 %) | 1 (9 %) | 0 | 0 |
Influenza- related death | 2 (9 %) | 2 (18.2 %) | 0 | 0 |